Difference between revisions of "Cisplatin (Platinol)"
Jump to navigation
Jump to search
m |
|||
| Line 8: | Line 8: | ||
Dosing | Dosing | ||
| − | + | *Renal dose adjustments | |
| − | + | *Hepatic dose adjustments | |
Routes of administration: IV | Routes of administration: IV | ||
| Line 16: | Line 16: | ||
Side effects | Side effects | ||
| − | + | *Patient information for informed consent | |
| − | + | *patient drug information | |
[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin] | [http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin] | ||
Revision as of 05:34, 13 November 2011
Template to be used for chemotherapies:
Mechanism
- Platinum analog, alkylating-like
- metabolism
- Excretion: renal ~90%, bile 10%
- CYP450: unknown
Dosing
- Renal dose adjustments
- Hepatic dose adjustments
Routes of administration: IV
- Vesicant?
- Antidote?
Side effects
- Patient information for informed consent
- patient drug information
List of regimens containing cisplatin